We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hend.Glbl.Tst | LSE:HGL | London | Ordinary Share | GB0003184024 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 410.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/4/2016 18:03 | So, it's "Good bye from me and good bye from him!" | pvb | |
16/4/2016 18:01 | So the votes are in and this one is ready to roll over. Interestingly, quite a lot (~38%) voted to roll over into BNKR rather than HINT. | pvb | |
23/3/2016 18:07 | Reconstruction proposals, circular going to shareholders: | pvb | |
11/2/2016 23:28 | ...and back down again. | pvb | |
01/2/2016 17:16 | Ah! I was wondering what to do about these recently. Thinking it didn't really seem to be going anywhere. I originally bought in to go alongside Bankers (BNKR) as it was cheaper at the time and had a somewhat higher yield. But the yield has remained flat and Bankers seems to perform better. I was thinking of selling and putting the proceeds into BNKR. They will be offering an option to roll over into Bankers as an alternative to HINT. I will have to do some more thinking. ;-) | pvb | |
01/2/2016 14:24 | Going to merge with HINT by the look of it because of the large discount and small size. Well, that announcement narrowed the discount a bit. | argoal | |
28/1/2016 13:38 | At about a 14% discount at present. NAV ~ 395p as against current shareprice of under 340p. | pvb | |
18/1/2016 22:15 | And is again. | pvb | |
24/8/2015 22:19 | This has certainly taken a hammering. | pvb | |
19/2/2015 23:16 | Latest factsheet here: | pvb | |
28/11/2014 20:10 | NAV now at about 425p. | pvb | |
25/11/2014 22:29 | This has been looking a lot more perky of late! | pvb | |
25/10/2014 14:29 | NAV currently about 400p, so discount now around 12.5% | pvb | |
26/8/2014 10:14 | Current NAV about 410p now | pvb | |
01/7/2014 16:36 | Current NAV about 398p | pvb | |
05/4/2014 01:00 | 2013 YE Results: Hasn't really gone anywhere since the previous YE, has it? Same div as last year, 10p, paid partially out of reserves (as last year) as eps 9.35p, last year was 9.57p. | pvb | |
11/12/2013 18:07 | Change of portfolio manager! Brian O'Neill to retire, to be replaced by Wouter Volckaert from 31 January 2014. | pvb | |
21/8/2013 16:23 | Prices are getting volatile! | pvb | |
29/5/2013 08:18 | Thanks pvb. I'd missed that they were changing the mandate. I have no problem with a bit more diversity in the mix. | argoal | |
28/5/2013 16:05 | Mandate change went through. Now will move to single index MSCI Worldwide (?) bench mark and therefore hold less UK equities and more US and emerging markets. | pvb | |
25/1/2013 20:30 | Well I bought in a while ago. Of course it has risen - like everything else! It will be interesting to see how it compares to Bankers (BNKR) in the longer term. | pvb | |
03/12/2012 13:36 | I had my eye on bankers as well but the discount here was too great to resist. Currently discount at 10% for a basket of global blue chip companies. Top 10 holding below. Also like the management charge of 0.87% pa. Lower than most ITs. Royal Dutch Shell PLC B 3.9 Nestle SA 3.1 Vodafone Group Plc 3.0 BP Plc 2.8 HSBC Holdings Plc 2.8 Syngenta AG 2.6 Novartis AG 2.5 GlaxoSmithKline Plc 2.5 British American Tobacco 2.2 Oracle Corporation 2.2 Apolgies for lack of formatting. | argoal | |
02/12/2012 09:47 | I'm thinking of buying in. I already hold Bankers IT (BNKR). Bankers is currently reported as having a smaller discount than usual, hence my interest in HGL, which also now has a higher yield. | pvb | |
28/9/2012 08:46 | Anyone else follow this IT? Global exposure. 3% yield. Good discount to Nav Objective: The Company seeks long-term capital growth from a concentrated portfolio of international equities with a secondary objective to increase dividends over the longer term. The Manager generally holds stocks of large and medium sized companies listed on major equity markets and aims to outperform the composite benchmark by at least 2% within a target tracking error of not more than 5%. The core of the portfolio comprises 40 stocks, which normally represent 80% of the portfolio. The Manager seeks to add further value by using the Company's trading subsidiary to take advantage of short-term opportunities. Total return performance 1 year 3 years 5 years 10 years % % % % Net asset value per share (with debt at fair value) -2.5 +52.4 +31.4 +107.5 Mid-market price per ordinary share -8.7 +53.5 +39.6 +136.7 FTSE All-Share Index -0.3 +56.9 +9.3 +65.6 MSCI World Index ex UK (in sterling terms) -1.1 +46.0 +18.4 +44.5 Benchmark index(1) -0.7 +51.5 +13.8 +55.0 | argoal |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions